U.S. Senator Collins' Statement on Terrorist Attacks in Brussels

 WASHINGTON, D.C. – U.S. Senator Susan Collins, a member of the Senate Intelligence Committee, and former Chairman of the Homeland Security Committee, released the following statement today on the terrorist attack in Brussels, Belgium:
"The United States stands firmly with the government and the people of Belgium in the face of this horrific act of terrorism.


Collins, King and Poliquin Send Letter in Support of Trade Adjustment Assistance for Madison Paper Workers

WASHINGTON, D.C. – Yesterday, U.S. Senators Susan Collins and Angus King and Representative Bruce Poliquin sent a letter to U.S. Department of Labor Secretary Thomas Perez in support for the recently filed Trade Adjustment Assistance (TAA) petition to assist the more than 200 workers at Madison Paper Industries who are being displaced in large measure to increased foreign competition.


Weekly Column: Preserving Our Veterans’ Local Access to Health Care

At the height of a terrible winter storm in Aroostook County in January 2014, veteran Peter Miesburger suffered a broken hip that required emergency surgery.  Prior to the implementation of a pilot program known as Access Received Closer to Home (ARCH), his injury would have necessitated an eight hour, 500-mile roundtrip drive to the Togus VA Medical Center in Augusta.  Instead of enduring this painful and bumpy ride, he was able to receive care at his local hospital, Cary Medical Center in Caribou, through the ARCH program and successfully recuperate closer to his family and friends. 


Chairman Collins, Ranking Member McCaskill to Hold Second Hearing in Senate Aging Committee’s Bipartisan Investigation:

Interim CEO of Turing Pharmaceuticals, Ronald Tilles, to Appear


WASHINGTON, D.C.—Senate Aging Committee Chairman Susan Collins and Ranking Member Claire McCaskill will hold a hearing TOMORROW, Thursday, March 17, titled: Sudden Price Spikes in Decades-Old Rx Drugs: Inside the Monopoly Business Model. It is the second hearing in their ongoing bipartisan investigation.